Schizophrenia & Psychosis
Search All News
Boosting thalamic activity could help treat cognitive symptoms in schizophrenia related to altered prefrontal cortex function
Source:The New York Times
Chacku Mathai, a project director with OnTrackNY, thinks about whether, if the perfect antipsychotic existed, he would take it. “My experience is so rich,” he said, “I wouldn’t trade it for anything.”
Dr. Aaron Slan, a fourth-year psychiatry resident at Columbia University describes a patients who was acting like someone who had a schizophrenia spectrum illness, but turned out to have COVID-19.
New insights into genetic architecture of disease hold promise for improved risk prediction and novel drug design.
- August 28, 2019
Dr. Gary Brucato, the Center of Prevention and Evaluation's Assistant Director, breaks down some of the early warning signs and symptoms of possible emergent psychotic illness.
Source:Psychiatry & Behavioral Health Learning NetworkAugust 14, 2019
This study “adds to a growing literature of using electrophysiological outcomes, including mismatch negativity as predictive biomarkers,” commented Dr. Joshua Kantrowitz.
- May 31, 2019
In this first episode of Inside Schizophrenia, Rachel Star Withers, a diagnosed schizophrenic, co-host Gabe Howard and special guest Dr. Ali Mattu explore this often misrepresented mental illness.
- April 15, 2019
Columbia Psychiatrists suggest that researchers, pharmaceutical companies, and the FDA reconsider placebo-controlled, relapse prevention studies in schizophrenia.
Source:JAMAApril 10, 2019
Dr. Jeffrey Lieberman and colleagues conclude that the time has come to cease the use of placebo in relapse prevention studies and encourage the use of active comparators.
- March 21, 2019
A new study from Columbia University and New York State Psychiatric Institute offers insight into the development of delusions, which could lead to better treatments for people with psychosis.
Source:MD MagazineMarch 20, 2019
“What happens that leads people to relapse is that many don’t want to stay on medication and they’re not adherent,” says Dr. Jeffrey A. Lieberman.
Source:MD ALERTFebruary 28, 2019
"I expect that clinicians will change their practices by prescribing fewer benzodiazepines and more antidepressants for people with schizophrenia," Dr. T. Scott Stroup said.
Source:NewsDayFebruary 23, 2019
Schizophrenia and other psychotic disorders affect each person differently and vary in severity, said Dr. Lisa Dixon.
Source:HealioFebruary 21, 2019
“The effectiveness of combinations of antipsychotic medications remains unclear; reviews of this treatment strategy agree on the need for further investigation,” Dr. T. Scott Stroup and team wrote.